Mendoza-Vázquez G, Espinoza-Gómez F, Guzmán-Silahua S, Nava-Zavala AH

Idioma: Español
Referencias bibliográficas: 34
Paginas: 48-57
Archivo PDF: 263.12 Kb.

RESUMEN

La prehipertensión es una condición definida en un rango de 120-139/80-89 mmHg que puede afectar hasta al 52% de la población mundial. Los individuos con prehipertensión tienen un riesgo dos o tres veces mayor de desarrollar hipertensión arterial (HTA). La HTA puede afectar hasta a un 70% de la población adulta. Por otra parte, la prehipertensión es en sí misma un factor de riesgo cardiovascular que en conjunto con otros facilita la presencia de enfermedad cardiovascular. Existe la necesidad de divulgar el conocimiento de los conceptos de la prehipertensión mediante estrategias que permitan su amplia difusión. Estas acciones podrían favorecer la toma de medidas preventivas para detener la creciente incidencia de la HTA y evitar o retrasar el desarrollo de enfermedades cardiovasculares.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Bharath T, Manjula P. Lipid profile but not highly sensitive C-reactive protein helps distinguish prehypertensives from normal subjects. J Nat Sci Biol Med. 2015; 6 (2): 347-350.

2. Albarwani S, Al-Siyabi S, Tanira MO. Prehypertension: Underlying pathology and therapeutic options. World J Cardiol. 2014; 6 (8): 728-743.

3. Mallik D, Mukhopadhyay DK, Kumar P, Sinhababu A. Hypertension, prehypertension and normotension among police personnel in a district of West Bengal, India. J Assoc Physicians India. 2014; 62 (11): 12-16.

4. Jiang M, Gong D, Fan Y. Serum uric acid levels and risk of prehypertension: a meta-analysis. Clin Chem Lab Med. 2017; 55 (3): 314-321.

5. INSP. Encuesta Nacional de Salud y Nutrición de Medio Camino, resultados nacionales. Instituto Nacional de Salud Pública; 2016. [Consultado el 02 junio de 2017). Disponible en: http://promocion.salud.gob.mx/dgps/descargas1/doctos_2016/ensanut_mc_2016-310oct.pdf

6. Guzmán-Guzmán IP, Salgado-Goytia L, Muñoz-Valle JF, Salgado-Bernabé AB, Quiroz-Vargas I, Parra Rojas I. Prehypertension in a Mexican population: influence of age, gender, and body fat. Clin Exp Hypertens. 2013; 35 (1): 67-73.

7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289 (19): 2560-2572.

8. Hwang YC, Fujimoto WY, Kahn SE, Leonetti DL, Boyko EJ. Greater visceral abdominal fat is associated with a lower probability of conversion of prehypertension to normotension. J Hypertens. 2017; 35 (6): 1213-1218.

9. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N et al. Trial of preventing hypertension (TROPHY) study investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006; 354 (16): 1685-1697.

10. De Marco M, de Simone G, Roman MJ, Chinali M, Lee ET, Russell M et al. Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension. 2009; 54 (5): 974-980.

11. Donahue RP, Stranges S, Rafalson L, Dmochowski J, Dorn J, Trevisan M. Risk factors for prehypertension in the community: a prospective analysis from the Western New York Health Study. Nutr Metab Cardiovasc Dis. 2014; 24 (2): 162-167.

12. Hadaegh F, Hasheminia M, Abdi H, Khalili D, Bozorgmanesh M, Arshi B, Azizi F. Prehypertension tsunami: a decade follow-up of an Iranian adult population. PLoS One. 2015; 10 (10): e0139412.

13. Yao W, Sun Y, Wang X, Si Q, Chen H, Wan Z. High prevalence of metabolic syndrome in a middle-aged and elderly population with prehypertension in Tianjin. Clin Exp Hypertens. 2015; 37 (5): 369-374.

14. Denton KM, Hilliard LM, Tare M. Sex-related differences in hypertension: seek and ye shall find. Hypertension. 2013; 62 (4): 674-677.

15. Pausova Z, Mahboubi A, Abrahamowicz M, Leonard GT, Perron M, Richer L et al. Sex differences in the contributions of visceral and total body fat to blood pressure in adolescence. Hypertension. 2012; 59 (3): 572-579.

16. Muchanga M, Lepira FB, Tozin R, Mbelambela EP, Ngatu NR, Sumaili EK et al. Prevalence and risk factors of pre-hypertension in Congolese pre and post menopausal women. Afr Health Sci. 2016; 16 (4): 979-985.

17. Morales G, Guillen-Grima F, Muñoz S, Belmar C, Schifferli I, Muñoz A, Soto A. Cardiovascular risk factors among first and third year university students. Rev Med Chil. 2017; 145 (3): 299-308.

18. Martínez SM, Leiva OAM, Sotomayor CC, Victoriano RT, Von Chrismar PAM, Pineda BS. Cardiovascular risk factors among university students. Rev Med Chil. 2012; 140 (4): 426-435.

19. Tayem YI, Yaseen NA, Khader WT, Abu Rajab LO, Ramahi AB, Saleh MH. Prevalence and risk factors of obesity and hypertension among students at a central university in the West Bank. Libyan J Med. 2012; 7.

20. Shin N, Hyun W, Lee H, Ro M, Song K. A study on dietary habits, heath related lifestyle, blood cadmium and lead levels of college students. Nutr Res Pract. 2012; 6: 340-348.

21. De Almeida AR, Monte-Alegre S, Zanini MB, Souza AL, Etchebehere M, Gontijo JA. Association between prehypertension, metabolic and inflammatory markers, decreased adiponectin and enhanced insulinemia in obese subjects. Nutr Metab (Lond). 2014; 11: 25.

22. Hanley AJ, Karter AJ, Festa A, D’Agostino R Jr, Wagenknecht LE, Savage P et al.; Insulin Resistance Atherosclerosis Study. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes. 2002; 51 (8): 2642-2647.

23. Freedman DS, Ford ES. Are the recent secular increases in the waist circumference of adults independent of changes in BMI? Am J Clin Nutr. 2015; 101 (3): 425-431.

24. Okosun IS, Boltri JM, Anochie LK, Chandra KM. Racial/ethnic differences in prehypertension in American adults: population and relative attributable risks of abdominal obesity. J Hum Hypertens. 2004; 18 (12): 849-855.

25. Ma M, Tan X, Zhu S. Prehypertension and its optimal indicator among adults in Hubei Province, Central China, 2013-2015. Clin Exp Hypertens. 2017; 7: 1-7.

26. Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY. Minimum waist and visceral fat values for identifying Japanese Americans at risk for the metabolic syndrome. Diabetes Care. 2007; 30 (1): 120-127.

27. Markus MR, Stritzke J, Siewert U, Lieb W, Luchner A, Döring A et al; MONICA/KORA Investigators. Variation in body composition determines long-term blood pressure changes in pre-hypertension: the MONICA/KORA (Monitoring Trends and Determinants on Cardiovascular Diseases/Cooperative Research in the Region of Augsburg) cohort study. J Am Coll Cardiol. 2010; 56 (1): 65-76.

28. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension. 2006; 47 (3): 410-414.

29. Chen YL, Hsu CH, Hsieh CH, Wu CZ, Lin JD, Chang JB et al. High normotension is associated with future metabolic syndrome but not cardiovascular disease: a 10-year longitudinal study. Medicine (Baltimore). 2017; 96 (25): e7227.

30. Sung KC, Park HY, Kim MJ, Reaven G. Metabolic markers associated with insulin resistance predict type 2 diabetes in Koreans with normal blood pressure or prehypertension. Cardiovasc Diabetol. 2016; 15: 47.

31. Lotufo PA, Baena CP, Santos IS, Bensenor IM. Serum uric acid and prehypertension among adults free of cardiovascular diseases and diabetes: baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Angiology. 2016; 67 (2): 180-186.

32. Tanida M, Shen J, Horii Y, Matsuda M, Kihara S, Funahashi T et al. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med (Maywood). 2007; 232: 390-397.

33. Booth JN 3rd, Li J, Zhang L, Chen L, Muntner P, Egan B. Trends in prehypertension and hypertension risk factors in US adults: 1999-2012. Hypertension. 2017; 70 (2): 275-284.

34. Pannarale G, Moroni C, Acconcia MC, Pannitteri G, Truscelli G, Valente L et al. The natural history of prehypertension. A 20-year follow-up. Eur Rev Med Pharmacol Sci. 2017; 21 (6): 1329-1334.